Premixed formulation of piperacillin sodium and tazobactam sodium injection
    1.
    发明授权
    Premixed formulation of piperacillin sodium and tazobactam sodium injection 有权
    哌拉西林钠和他唑巴坦钠注射液的预混制剂

    公开(公告)号:US06207661B1

    公开(公告)日:2001-03-27

    申请号:US09255513

    申请日:1999-02-22

    IPC分类号: A61K3143

    摘要: The present invention provides a premixed form of a buffered piperacillin product having a near neutral pH and capable of a shelf life of at least nine months, with freezer storage (−20° C. or lower), or a refrigerated shelf life of up to 14 days at about 5° C. The piperacillin may additionally contain a tazobactam component to inactivate beta-lactamases that commonly cause resistance to penicillins, allowing the piperacillin component to destroy susceptible bacteria. With the addition of dextrose, the premixed composition is physiologically isosmotic.

    摘要翻译: 本发明提供了一种具有接近中性pH并且能够保存至少9个月的缓冲哌拉西林产品的预混合形式,其中冷冻储存(-20℃或更低)或冷藏保存期限至多 在约5℃下14天。哌拉西林可另外含有他唑巴坦组分以灭活通常对青霉素产生抗性的β-内酰胺酶,允许哌拉西林组分破坏易感染的细菌。 通过加入葡萄糖,预混组合物是生理上等渗的。